C9ORF5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.873400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.764600E-01
Normal-vs-Stage2
7.260400E-01
Normal-vs-Stage3
2.717400E-01
Normal-vs-Stage4
3.189000E-01
Stage1-vs-Stage2
4.923600E-01
Stage1-vs-Stage3
6.612400E-02
Stage1-vs-Stage4
8.424800E-01
Stage2-vs-Stage3
1.504200E-01
Stage2-vs-Stage4
4.378800E-01
Stage3-vs-Stage4
6.951700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.087800E-01
Normal-vs-AfricanAmerican
5.380000E-01
Normal-vs-Asian
8.042800E-01
Caucasian-vs-AfricanAmerican
4.943400E-01
Caucasian-vs-Asian
9.871400E-01
AfricanAmerican-vs-Asian
6.750200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.942800E-01
Normal-vs-Female
6.823000E-01
Male-vs-Female
8.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.675800E-01
Normal-vs-Age(41-60Yrs)
3.495800E-01
Normal-vs-Age(61-80Yrs)
8.373200E-01
Normal-vs-Age(81-100Yrs)
5.968600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.621400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.581400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.673800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.619000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.296050E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.403800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.648600E-01
Normal-vs-Daily Drinker
8.822000E-01
Normal-vs-Weekly Drinker
9.346000E-01
Normal-vs-Occasional Drinker
4.601200E-01
Normal-vs-Social Drinker
4.624200E-01
Non Drinker-vs-Daily Drinker
5.009400E-01
Non Drinker-vs-Weekly Drinker
6.475000E-01
Non Drinker-vs-Occasional Drinker
6.504000E-02
Non Drinker-vs-Social Drinker
8.650300E-02
Daily Drinker-vs-Weekly Drinker
9.521400E-01
Daily Drinker-vs-Occasional Drinker
2.842400E-01
Daily Drinker-vs-Social Drinker
1.765200E-01
Weekly Drinker-vs-Occasional Drinker
3.745000E-01
Weekly Drinker-vs-Social Drinker
2.192200E-01
Occasional Drinker-vs-Social Drinker
4.662600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.290100E-02
Normal-vs-Grade 2
4.041700E-02
Normal-vs-Grade 3
9.104300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.668200E-01
Grade 1-vs-Grade 3
6.149600E-01
Grade 1-vs-Grade 4
5.290100E-02
Grade 2-vs-Grade 3
8.849600E-01
Grade 2-vs-Grade 4
4.041700E-02
Grade 3-vs-Grade 4
9.104300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.844800E-01
Normal-vs-NonDiabetic
7.446600E-01
Diabetic-vs-NonDiabetic
6.536000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.412800E-01
Normal-vs-NoPancreatitis
7.880200E-01
Pancreatitis-vs-NoPancreatitis
7.219200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.762800E-01
Normal-vs-N1
7.197800E-01
N0-vs-N1
6.435200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.945600E-01
Normal-vs-TP53-NonMutant
4.895800E-01
TP53-Mutant-vs-TP53-NonMutant
9.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
